CC vs PFE · P/E 72, rev $1.36B vs P/E 20, rev $62.58B
Chemours Co (CC) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Chemours Co (CC) is a specialty chemicals company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported CC revenue for 2024-12-31 was $1.36B. Net income was -$8.0M. Revenue was down 9.9% from 2024-09-30 to 2024-12-31. CC currently screens at market cap $1.94B and trailing P/E 71.8.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
CC currently screens at market cap $1.94B and trailing P/E 71.8. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the CC and PFE stock pages for the full models.
Not investment advice.